The doses were
shipped to the NIAID
earlier this year.
ruggero spano
The investigational doses include the use of the
adjuvant, aluminum hydroxide
(alum), that could increase the vaccine's
effectiveness and enable the use of less antigen in each
dose.
As the world leader in research, development and manufacturing of
influenza vaccine
, sanofi pasteur is actively involved in other projects in
the U.
* In France, sanofi pasteur
was recently awarded a contract by the French
Ministry of Health to produce pre-pandemic vaccine
in 2005 to create a
1.estu goceano
McClellan, "In less than a year
seniors will get critical help with
access to 21st century, prevention-
oriented medial care.S.S.
* In France, sanofi pasteur
sponsored the first clinical trials of an H5N1
pre-pandemic influenza vaccine candidate that
compared vaccines with and
without adjuvants.4 million dose stockpile with the H5N1 candidate
studied in this
trial.internatzionale estu
K.
Sanofi pasteur, the vaccines business of the sanofi-aventis
Group, sold
more than a billion doses of vaccine in 2005, making it possible to protect
more than
500 million people across the globe, which is about 1.inno internatzionale
headquarters in Swiftwater, PA.
About sanofi-aventis
Sanofi-aventis is the world's third-largest pharmaceutical company
,
ranking number one in Europe.com
Forward-Looking Statements
This press release
contains forward-looking statements as defined in the
Private Securities Litigation Reform Act of
1995. Forward-looking statements are generally identified by the words
"expect," "anticipates,"
"believes," "intends," "estimates," "plans" and
similar expressions.com
sotzied sufueddu
Today's announcement
is a vital step to
improving the health of Hispanic Medicare beneficiaries," Dr.org
National
Institutes of Health
(NIH), part of the U. FLUPAN is intended to improve the level of pandemic
preparedness in the EU Sanofi pasteur is to produce a vaccine to combat
another strain
with pandemic potential (H7N1) that will be used in a
FLUPAN clinical study.sotzied goceano
S.
The bulk
-concentrate and the investigational doses were produced at sanofi
pasteur's U. Preliminary results
of the trial, announced on Dec.sotzied sanna
McClellan, for taking into
account the comments of Hispanic community
health leadership from throughout
the country and constructing final rules that will make the new
Medicare
prescription drug benefit easier to enroll in and more comprehensive," said
Dr.hispanichealth
. The end result
could be a greater number of doses available to immunize more people.S.S. Although
sanofi-aventis' management believes that the
expectations reflected in such forward-looking statements
are reasonable,
investors are cautioned that forward-looking information and statements are
subject
to various risks and uncertainties, many of which are difficult to
predict and generally beyond the
control of sanofi-aventis, that could cause
actual results and developments to differ materially
from those expressed in,
or implied or projected by, the forward-looking information and statements
.
indiritzos italianu
The MMA
provides for the first time a prescription drug benefit (Medicare Part D) for
beneficiaries
in fee-for-service Medicare.S. The
bulk doses were produced and are being stored, and can be
formulated and
filled upon government request. There
are also contacts concerning
pandemic preparedness between sanofi
pasteur and other governments in Europe and worldwide
.inno sotzied
The much-anticipated rules announced today by CMS implement the Medicare
Modernization Act
(MMA) passed by Congress a little over a year ago. Delgado. Bilingual health
information specialists
can also refer callers to a local health care provider
in their community.
These activities
are further examples of sanofi pasteur's commitment to
global pandemic preparedness.S.'s National
Institute for Biological
Standards and Control (NIBSC). The clinical lots are being developed
in
collaboration with the French health authorities, NIBSC and the European
Agency
for the Evaluation of Medicinal Products (EMEA).
* Sanofi pasteur is the only vaccine manufacturer
to participate in
FLUPAN, a European Union (EU) funded collaboration. Backed by a world-class
R+D organization,
sanofi-aventis is developing leading positions in seven major therapeutic
areas:
cardiovascular disease, thrombosis, oncology, metabolic diseases,
central nervous system, internal
medicine, and vaccines.ruggero cun
The National Alliance for Hispanic Health is the nation's action forum
for
Hispanic health, delivering services to over 12 million persons every year.
For more information
, visit the Alliance's website:
http://www.S. FLUPAN partners
include NIBSC (UK), the University
of Reading (UK), Istituto Superiore
di Sanita (Italy), the Health Protection Agency (UK) and
the University
of Bergen (Norway). For more information, please visit:
http://www. Other
than as required by applicable law, sanofi-
aventis does not undertake any obligation to update or
revise any forward-
looking information or statements.goceano presentada
Over 2 Million Hispanics Will Get Prescription
Coverage Through New Medicare Rules
According to CMS Administrator Dr. Mark B. government
including investigational doses
formulated with an adjuvant. The additional bulk concentrate vaccine
just produced
is valued at $50 million and will support U.
* In September 2004, the company
signed a contract with HHS to produce two
million doses of bulk vaccine derived from the H5N1
viral strain.S.
In Australia:
* A contract has also been signed with the Australian
government for the
supply of vaccine in the event of a pandemic influenza outbreak.italianu goro
S. and Europe
with the goal of developing a vaccine to protect against a
pandemic influenza virus.
15
, 2005, demonstrated a good immune response in a significant number of
volunteers.5 million
per
day. Media Relations
Tel: + 33-(0)4-37-37-78-97 Tel: +1-570-839-4446
Fax: + 33-(0)4-37-37-77-89 Len.estu etnografico
"Having access to the medicines they need is
a critical part of
healthy aging for all seniors.
The Alliance also announced the availability
of help with understanding
new Medicare benefits through the Alliance's 1-866-SU-FAMILIA (1-866-783
-2645)
National Hispanic Family Health Helpline. Department of Health and Human Services (HHS), 15
,000
investigational doses of a vaccine to protect against the H5N1 influenza
strain. The
strain was provided by the U. By this agreement, the company could also provide enough vaccine
to protect up to 28 million people in the event of a pandemic being
declared, once the
actual virus strain responsible is identified.faeddant estu
Jane L.
"We applaud CMS and its Administrator
, Dr.S.S.
* In September 2005, the HHS awarded a contract to sanofi pasteur to
produce
a vaccine to help protect against the H5N1 influenza virus
strain.gonella logudoresu
New rules announced by
the Centers for Medicare and Medicaid Services
(CMS) mean that over 2 million Hispanic Medicare recipients
will be able to
pay for the medicines they need," said Dr.
Sanofi pasteur has shipped to the
U.
Once the optimal dosage is established, the bulk-concentrate antigen will be
ready for final
formulation and filling into doses. The clinical studies for the
vaccine are being conducted
by the NIAID.Lavenda@sanofipasteur.In custa categora agatades sos sitos in limba sarda chi faeddant
de Arte.
sardu internatzionale
Delgado
concluded. and LYON, France, Sanofi pasteur,
the vaccines business of the sanofi
-aventis Group (NYSE: SNY), has delivered
more H5N1 vaccine to the U.
The additional H5N1 bulk
-concentrate vaccine represents a broadening of a
contract the company signed in September 2005 with
the U. The H5N1 viral strain has been identified by
global health authorities as being a potential
cause of a pandemic.
Sanofi pasteur's Global Commitment to Pandemic Preparation
In
the U. The trials are being undertaken to speed the time for
regulatory review should a pandemic
vaccine be needed quickly.presentada miali
WASHINGTON, "Today is a landmark day in health
care. Callers get
free reliable and
confidential health information in Spanish and English.sanofi pasteur Delivers
More H5N1 Vaccine for U.S. Government Pandemic Initiatives
- New investigational doses include
formulation with an adjuvant;
Additional stockpile vaccine prepared -
SWIFTWATER, Pa.
* In November 2004, the HHS awarded a contract to sanofi pasteur to expand
and safeguard the egg supply needed to produce influenza vaccine and to
formulate
each year investigational doses for a potential pandemic
influenza vaccine.
* In
April 2005, the HHS awarded a contract to sanofi pasteur to
accelerate the development of a
cell-culture influenza vaccine in the
U. The data from
these studies will be used
to submit a "mock dossier" submitted to the
EMEA to accelerate the license approval process
in the event of a
pandemic.sanna faeddant
These statements include
financial projections and estimates
and their underlying assumptions,
statements regarding plans, objectives and expectations with respect
to future
operations, products and services, and statements regarding future
performance.italianu estu
" Medicare
recipients can get more information, in Spanish or English,
on new Medicare benefits by calling 1
-800-MEDICARE (1-800-633-4227). Prepared with different levels of antigen, the investigational doses
will be used in the NIH's clinical studies to determine the optimal
formulation of the vaccine
. government stockpile. The agreement provides for additional
fees to be paid to sanofi pasteur
for storage of the vaccine as well as
for formulation and filling of the vaccine upon government
request.
In Europe, sanofi pasteur initiated and runs a large range of projects.aiscurtade etnografico
In
addition, the company has completed production of additional bulk-
concentrate of the H5N1 vaccine
antigen for the U., sanofi pasteur has a number of pandemic-related agreements
with the U.sanofipasteur
.S.italianu spano
site in Swiftwater, PA.S. The sanofi-aventis
Group is listed in Paris (EURONEXT: SAN) and in New
York (NYSE: SNY).aiscurtade londra
Medicare beneficiaries will
receive the new prescription benefit detailed in today
's rules starting
January 1, 2006. All people with Medicare are now one huge step closer
to having
a new drug benefit and new health plan options, regardless of
income.internatzionale cun
Delgado, President and CEO
of the National Alliance for Hispanic Health (the Alliance), the Nation's
leading Hispanic health
advocacy group. Department of
Health and Human Services (HHS) to produce a stockpile of the H5N1
vaccine
valued at $100 million. Forward-looking statements
are statements that are not historical
facts.italianu miali
Department of Defense
requirements. government involving development of pandemic vaccine stockpiles
,
production of investigational doses and the development cell-culture
technology, including:
* In May 2004, sanofi pasteur contracted with the NIAID to produce 8,000
investigational
doses of the H5N1 influenza strain. and the design of a U.-based cell-culture vaccine manufacturing
facility. The $150 million contract calls for sanofi pasteur to
manufacture the vaccine
in bulk-concentrate form at its U. The company offers the broadest range of vaccines, providing protection
against 20 bacterial and viral diseases.
These risks and uncertainties include those discussed
or identified in the
public filings with the SEC and the AMF made by sanofi-aventis, including
those
listed under "Risk Factors" and "Cautionary Statement Regarding Forward-
Looking Statements" in sanofi
-aventis' annual report on Form 20-F for the year
ended December 31, 2004.
sanofi pasteur
sanofi pasteur
Alain BERNAL Len LAVENDA
Vice-President Corporate Communications U.sufueddu estu
Working overtime to stay the Web's best reference!
-> Show SiteSeek's List of Web Sites For This Topic (Not Yet Peer Reviewed)
Loading...
(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)